Abstract:Chronic arsenic exposure is a global health hazard significantly associated with the development of deleterious cutaneous changes and increased keratinocyte cancer risk. Although arsenic exposure is associated with broad-scale cellular and molecular changes, gaps exist in understanding how these changes impact the skin and facilitate malignant transformation. Recently developed epigenetic "clocks" can accurately predict chronological, biological and mitotic age, as well as telomere length, on the basis of tissue DNA methylation state. Deviations of predicted from expected age (epigenetic age dysregulation) have been associated with numerous complex diseases, increased all-cause mortality and higher cancer risk. We investigated the ability of these algorithms to detect molecular changes associated with chronic arsenic exposure in the context of associated skin lesions. To accomplish this, we utilized a multi-algorithmic approach incorporating seven "clocks" ( Horvath, Skin&Blood, PhenoAge, PCPhenoAge, GrimAge, DNAmTL and epiTOC2 ) to analyze peripheral blood of pediatric and adult cohorts of arsenic-exposed (n = 84) and arsenic-naïve (n = 33) individuals, among whom n = 18 were affected by skin lesions. Arsenic-exposed adults with skin lesions exhibited accelerated epigenetic ( Skin&Blood : + 7.0 years [95% CI 3.7; 10.2], q = 6.8 × 10 –4 ), biological ( PhenoAge: + 5.8 years [95% CI 0.7; 11.0], q = 7.4 × 10 –2 , p = 2.8 × 10 –2 ) and mitotic age ( epiTOC2: + 19.7 annual cell divisions [95% CI 1.8; 37.7], q = 7.4 × 10 –2 , p = 3.2 × 10 –2 ) compared to healthy arsenic-naïve individuals; and accelerated epigenetic age ( Skin&Blood: + 2.8 years [95% CI 0.2; 5.3], q = 2.4 × 10 –1 , p = 3.4 × 10 –2 ) compared to lesion-free arsenic-exposed individuals. Moreover, lesion-free exposed adults exhibited accelerated Skin&Blood age (+ 4.2 [95% CI 1.3; 7.1], q = 3.8 × 10 –2 ) compared to their arsenic-naïve counterparts. Compared to the pediatric group, arsenic-exposed adults exhibited accelerated epigenetic (+ 3.1 to 4.4 years (95% CI 1.2; 6.4], q = 2.4 × 10 –4 –3.1 × 10 –3 ), biological (+ 7.4 to 7.8 years [95% CI 3.0; 12.1] q = 1.6 × 10 –3 –2.8 × 10 –3 ) and mitotic age (+ 50.0 annual cell divisions [95% CI 15.6; 84.5], q = 7.8 × 10 –3 ), as well as shortened telomere length (− 0.23 kilobases [95% CI − 0.13; − 0.33], q = 2.4 × 10 –4 ), across all seven algorithms. We demonstrate that lifetime arsenic exposure and presence of arsenic-associated skin lesions are associated with accelerated epigenetic, biological and mitotic age, and shortened telomere length, reflecting altered immune signaling and genomic regulation. Our findings highlight the usefulness of DNA methylation-based algorithms in identifying deleterious molecular changes associated with chronic exposure to the heavy metal, serving as potential prognosticators of arsenic-induced cutaneous malignancy.

Marking Time: Epigenetic Aging May Partially Explain the Arsenic-Cardiovascular Disease Link

Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease

Epigenetic Clocks And Incident Heart Failure: The Atherosclerosis Risk In Communities

Arsenic Exposure and Epigenetic Aging: The Association with Cardiovascular Disease and All-Cause Mortality in the Strong Heart Study

Signatures of epigenetic, biological and mitotic age acceleration and telomere shortening are associated with arsenic-induced skin lesions

The impact of prenatal and early-life arsenic exposure on epigenetic age acceleration among adults in Northern Chile

Metal Mixtures and DNA Methylation Measures of Biological Aging in American Indian Populations

DNA Methylation Clocks in Aging: Categories, Causes, and Consequences

Epigenetic Clocks: In Aging-Related and Complex Diseases

Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing

DNA methylation aging clocks: challenges and recommendations

Healthy lifestyle, DNA methylation age acceleration, and incident risk of coronary heart disease

Epigenetic aging: more than just a clock when it comes to cancer.

Targeting the 'DNA methylation mark': Analysis of early epigenetic-alterations in children chronically exposed to arsenic

Exposure to Polycyclic Aromatic Hydrocarbons and Accelerated DNA Methylation Ageing: an Observational Study

The Blood DNA Methylation Clock GrimAge Is a Robust Surrogate for Airway Epithelia Aging

Underlying features of epigenetic aging clocks in vivo and in vitro

DNA methylation-based biomarkers and the epigenetic clock theory of ageing

Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging

An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease

Editor's Highlight: Modifying Role of Endothelial Function Gene Variants on the Association of Long-Term PM2.5 Exposure with Blood DNA Methylation Age: the VA Normative Aging Study.